Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting.
Roberto ScicaliAntonino Di PinoViviana FerraraAgata Maria RabuazzoFrancesco PurrelloSalvatore PiroPublished in: Acta diabetologica (2021)
In conclusion, PCSK9-i therapy significantly improved lipid and inflammatory profiles and PWV values in FH subjects; our results support the positive effect of PCSK9-i in clinical practice.